References
- Pangburn MK. The alternative pathway. In: Ross GD, ed. Immunobiology of the complement system. New York: Academic Press, Inc., 1986: 46-7, 57.
- Ross GD. Introduction. In: Ross GD, ed. Immunobiology of the complement system. New York: Academic Press, Inc., 1986:13.
- Weiler JM. Introduction. In: Whaley K, Loos M, Weiler JM. Complement in health and disease. 2nd ed. Dordrecht: Kluwer Academic Publishers, 1993:5.
- Rother K, Till GO. The complement system. Berlin: Springer-Verlag, 1988:61, 119.
- Chenoweth DE. Complement mediators of inflammation. In: Ross GD, ed. Immunobiology of the complement system. New York: Academic Press, Inc., 1986:72-3, 75.
- Sahu A, Morikis D, Lambris JD. Complement inhibitors targeting C3, C4, and C5. In: Lambris JD, Holers VM. Therapeutic interventions in the complement system. Totowa, NJ: Humana Press, 2000:76.
- O’Neill GJ, Yang SY, Tegoli J, et al. Chido and Rodgers blood groups are distinctive antigenic components of human complement C4. Nature 1978;273:668-70.
- Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Science, 1997:205.
- Lublin DM, Kompelli S, Storry JR, et al. Molecular basis of Cromer blood group antigens. Transfusion 2000;40:208-13.
- Atkinson JP, Kaine JL, Holers VM, et al. Complement and the rheumatic diseases. In: Ross GD, ed. Immunobiology of the complement system. New York: Academic Press, Inc., 1986:197-211.
- Boackle SA, Holers VM. Role of complement in the development of autoimmunity. In: Nemazee D, ed. B cell biology in autoimmunity: current directions in autoimmunity. Basel: Karger, 2003;6:154-68.
- Prodeus AP, Georg S, Shen L-M, et al. A critical role for complement in maintenance of self-tolerance. Immunity 1998;9:721-31.
- Hillmen P, Hall C, Marsh JCW, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2004;350:552-9.
- Yazdanbakhsh K, Kang S, Tamasauskas D, et al. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy. Blood 2003;101:5046-52.
- Mqadmi A, Zheng X, Song J, et al. Prevention of complement-mediated immune hemolysis by a small molecule compound. Biochem Biophys Res Commun 2004;325:1465-71.
- Mqadmi A, Abdulla Y, Yazdanbahksh K. Characterization of complement receptor 1 domains for prevention of complement-mediated red cell destruction. Transfusion 2005;45:234-44.